Level Bio AB (publ) (NGM:LEVBIO)
Sweden · Delayed Price · Currency is SEK 0.2600
+0.0300 (13.04%)
At close: Aug 14, 2026
Level Bio AB Market Cap
Level Bio AB has a market cap or net worth of 17.78 million as of August 14, 2026. Its market cap has decreased by -13.33% in one year.
Market Cap
17.78M
Enterprise Value
16.32M
Revenue
33.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
ChartMarket Cap Chart
Since September 18, 2006, Level Bio AB's market cap has decreased from 35.14M to 17.78M, a decrease of -49.40%. That is a compound annual growth rate of -3.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 17.78M | -13.33% |
| Dec 30, 2025 | 20.52M | 8.70% |
| Dec 30, 2024 | 18.88M | -27.02% |
| Dec 29, 2023 | 25.87M | -45.31% |
| Dec 30, 2022 | 47.30M | -70.97% |
| Dec 30, 2021 | 162.94M | 142.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Transiro Holding AB | 20.55M |
| Nexar Group AB | 20.11M |
| Hybricon AB | 19.77M |
| Diadrom Holding AB | 18.35M |
| Qbrick AB | 18.13M |
| Vaxxa AB | 17.78M |
| Aptahem AB | 14.68M |
| Trainimal AB | 14.32M |